Nano carriers for drug transport across the blood-brain barrier

被引:202
|
作者
Li, Xinming [1 ,2 ]
Tsibouklis, John [2 ]
Weng, Tingting [3 ]
Zhang, Buning
Yin, Guoqiang [1 ]
Feng, Guangzhu [1 ]
Cui, Yingde [1 ]
Savina, Irina N. [4 ]
Mikhalovska, Lyuba I. [4 ]
Sandeman, Susan R. [4 ]
Howel, Carol A. [4 ]
Mikhalovsky, Sergey V. [4 ,5 ]
机构
[1] Zhongkai Univ Agr & Engn, Sch Chem & Chem Engn, 24 Dongsha St, Guangzhou 510225, Guangdong, Peoples R China
[2] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England
[3] Guangdong Petr & Chem Technol Inst, Dept Chem Engn, Foshan, Peoples R China
[4] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England
[5] Nazarbayev Univ, Sch Engn, Astana, Kazakhstan
关键词
Blood-brain barrier; drug delivery; nanomaterials; SOLID LIPID NANOPARTICLES; PLASMA-PROTEIN ADSORPTION; IN-VITRO ASSESSMENT; TARGETED DELIVERY; POLYMERIC NANOPARTICLES; CNS DELIVERY; ANTICANCER DRUGS; QUANTUM DOTS; MAGNETIC NANOPARTICLES; COLLOIDAL CARRIERS;
D O I
10.1080/1061186X.2016.1184272
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Effective therapy lies in achieving a therapeutic amount of drug to the proper site in the body and then maintaining the desired drug concentration for a sufficient time interval to be clinically effective for treatment. The blood-brain barrier (BBB) hinders most drugs from entering the central nervous system (CNS) from the blood stream, leading to the difficulty of delivering drugs to the brain via the circulatory system for the treatment, diagnosis and prevention of brain diseases. Several brain drug delivery approaches have been developed, such as intracerebral and intracerebroventricular administration, intranasal delivery and blood-to-brain delivery, as a result of transient BBB disruption induced by biological, chemical or physical stimuli such as zonula occludens toxin, mannitol, magnetic heating and ultrasound, but these approaches showed disadvantages of being dangerous, high cost and unsuitability for most brain diseases and drugs. The strategy of vector-mediated blood-to-brain delivery, which involves improving BBB permeability of the drug-carrier conjugate, can minimize side effects, such as being submicrometre objects that behave as a whole unit in terms of their transport and properties, nanomaterials, are promising carrier vehicles for direct drug transport across the intact BBB as a result of their potential to enter the brain capillary endothelial cells by means of normal endocytosis and transcytosis due to their small size, as well as their possibility of being functionalized with multiple copies of the drug molecule of interest. This review provids a concise discussion of nano carriers for drug transport across the intact BBB, various forms of nanomaterials including inorganic/solid lipid/polymeric nanoparticles, nanoemulsions, quantum dots, nanogels, liposomes, micelles, dendrimers, polymersomes and exosomes are critically evaluated, their mechanisms for drug transport across the BBB are reviewed, and the future directions of this area are fully discussed.
引用
收藏
页码:17 / 28
页数:12
相关论文
共 50 条
  • [31] SATURABLE TRANSPORT OF AMPHETAMINE ACROSS BLOOD-BRAIN BARRIER
    PARDRIDG.WM
    CONNOR, JD
    EXPERIENTIA, 1973, 29 (03): : 302 - 304
  • [32] Measurement and Modeling of Transport Across the Blood-Brain Barrier
    Fan, Hanwen
    Cai, Qi
    Qin, Zhenpeng
    JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME, 2023, 145 (08):
  • [33] Transport of prion protein across the blood-brain barrier
    Banks, W. A.
    Robinson, Sandra M.
    Diaz-Espinoza, R.
    Urayama, A.
    Soto, C.
    EXPERIMENTAL NEUROLOGY, 2009, 218 (01) : 162 - 167
  • [34] Modeling glucose transport across the blood-brain barrier
    Qutub, AA
    SECOND JOINT EMBS-BMES CONFERENCE 2002, VOLS 1-3, CONFERENCE PROCEEDINGS: BIOENGINEERING - INTEGRATIVE METHODOLOGIES, NEW TECHNOLOGIES, 2002, : 2224 - 2225
  • [35] Drug penetration across the blood-brain barrier: an overview
    Mangas-Sanjuan, V.
    Gonzalez-Alvarez, M.
    Gonzalez-Alvarez, I.
    Bermejo, M.
    THERAPEUTIC DELIVERY, 2010, 1 (04) : 535 - 562
  • [36] Application of an in vivo brain microdialysis technique to studies of drug transport across the blood-brain barrier
    Deguchi, Y
    Morimoto, K
    CURRENT DRUG METABOLISM, 2001, 2 (04) : 411 - 423
  • [37] The in vitro blood-brain barrier: the assessment of drug transport to the brain
    Dehouck, MP
    Fenart, L
    Dehouck, B
    Cecchelli, R
    ANIMAL ALTERNATIVES, WELFARE, AND ETHICS, 1997, 27 : 869 - 872
  • [38] Transport of carbamazepine and drug interactions at blood-brain barrier
    Jing-jing Sun
    Lin Xie
    Xiao-dong Liu
    Acta Pharmacologica Sinica, 2006, 27 : 249 - 253
  • [39] Transport of carbamazepine and drug interactions at blood-brain barrier
    jing-jing SUN Lin XIE Xiao-dong LIU~2 Center of Drug Metabolism and Pharmacokinetics
    ActaPharmacologicaSinica, 2006, (02) : 249 - 253
  • [40] Transport of carbamazepine and drug interactions at blood-brain barrier
    Sun, JJ
    Xie, L
    Liu, XD
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (02) : 249 - 253